Since 2022 ,  global COVID 19 outbreak continues to wreak havoc, the conflict between Russia and Ukraineto slow recovery of the global economy  againen countersebacks, sharp increases in commodity prices, inflationary pressures and continue to intensify the pressure on the supply chain, global trade recovery under pressure At the same time, more frequent domestic outbreak, for part of the production and operation of an enterprise supply chain stability produced bigger pressureInthis case, with the implementation of a series of stable foreign trade policies, and the inherent advantages of China's pharmaceutical industry chain support, theforeign trade of pharmaceutical products has maintained a steady development. Among them, imports reached 28.6 billion US dollars, up 0.67% year on year; Exports reachedu $55.31 billion, up 1.5% year on year.